Key Points Interested in Moderna, Inc.? Here are five stocks we like better. Moderna plans to pursue regulatory filing for intismeran, its personalized mRNA cancer vaccine developed with Merck, ...

Four new COVID-19 vaccines have been approved for distribution in the U.S. for 2026-27, the federal Food and Drug Administration just announced. On Aug. 27, the FDA issued letters to Moderna, ...

Moderna, the biotechnology company that rose to prominence with one of the first messenger RNA vaccines against COVID-19, has won regulatory clearance in the United States for its first mRNA-based ...

Post-pandemic, investors bailed on what was once one of the most-followed biotech stocks amid pessimism about the company's ability to further monetize its mRNA technology. But then, as the company ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA on Aug. 5, 2026 approved a new mRNA-based flu vaccine. (Melissa Phillip/AP) After months of regulatory questioning, the ...

Labor Department Officials Frustrated With White House Over COVID-19 Vaccine and Testing Mandate The FDA Authorized a Booster ...